ARTICLE | Company News
Biovail Corp. International news
February 27, 1995 8:00 AM UTC
MMD said it is reviewing the motion and working on a counter motion. Two of MMD's U.S. patents covering Cardizem (diltiazem) - Nos. 4,894,240 and 5,002,776 - expire in 2007 and 2008, respectively. MMD has a third U.S. patent relating to the delivery system used in Cardizem. ...